Position in ROIV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$24,737
+$5,375 QoQ
Shares Held
699
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#395
of 497 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Salomon & Ludwin, LLC holds $981,895 across 36 Biotechnology names. ROIV ranks #15 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
1,699 | $93,343 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
227 | $84,369 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
159 | $78,980 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
895 | $77,820 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
595 | $72,935 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
200 | $63,218 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
763 | $62,237 | |
| 8 | ARGX |
Argenx SE
|
46 | $42,677 |
All Filings in ROIV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,737 | 699 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $19,362 | 699 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $15,168 | 699 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $10,575 | 699 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||